000 01392 a2200325 4500
005 20250514071140.0
264 0 _c20030630
008 200306s 0 0 eng d
022 _a0071-786X
024 7 _a10.1007/978-3-0348-8012-1_2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchultz, Richard M
245 0 0 _aPotential of p38 MAP kinase inhibitors in the treatment of cancer.
_h[electronic resource]
260 _bProgress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques
_c2003
300 _a59-92 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAngiogenesis Inhibitors
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCytokines
_xphysiology
650 0 4 _aEnzyme Inhibitors
_xchemical synthesis
650 0 4 _aHumans
650 0 4 _aInflammation
_xpathology
650 0 4 _aMitogen-Activated Protein Kinases
_xantagonists & inhibitors
650 0 4 _aNeoplasm Invasiveness
_xprevention & control
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _ap38 Mitogen-Activated Protein Kinases
773 0 _tProgress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques
_gvol. 60
_gp. 59-92
856 4 0 _uhttps://doi.org/10.1007/978-3-0348-8012-1_2
_zAvailable from publisher's website
999 _c12575526
_d12575526